Stock Tickers: DGX, AMGN, VFC, JSDA, HANS, GPS, HD, KR, WMT
Last night on CNBC’s MAD MONEY, Jim Cramer reviewed Several "fallen angel" stocks where darling stocks have fallen more than they should have. He notes the following:
1) Quest Diagnostics (DGX-NYSE) is one he said sold off too much on lost business, and after beating earnings here’s what he thinks.
2) Amgen (AMGN-NASDAQ) is one that Cramer thinks is worth defending. When this biotech reported earnings last week and we saw how the street was treating it, it’s obvious the street is think of Amgen as a regular Big Pharma company instead of a biotech.
3) Cramer again defended VF Corp (VFC-NYSE) as one that was oversold after the sold a low margin operation and he was out on it saying it will return to highs.
Cramer was also positive on Jones Soda (JSDA-NASDAQ), although he said since it ran on Monday to be patient and let it pull back. This was not his first Jonesing on Jones and here’s what he said in December when he said it was the next Hansen Natural (HANS-NASDAQ).
During the day yesterday on his STOP TRADING segment, Cramer hit Wal-Mart’s (WMT-NYSE) Lee Scott again for basically allowing Kroger (KR-NYSE) to regain some momentum that it had lost. Oddly enough he also said Bush was driving foreign investors away to other safe markets like Europe and that Bush was hurting what people will pay in the US for a market multiple.
Jon C. Ogg
January 30, 2007
Sponsored: Want to Retire Early? Here’s a Great First Step
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.